YAP/TAZ 121 and C8orf7648 act as negative regulators of ferroptosis by upregulating SLC7A11 transcription, thus driving resistance to sorafenib in hepatocellular carcinoma. This evidence concerns the gene SLC7A11 and hepatocellular carcinoma.